Epitalon

AOD9604 research peptide primarily promotes lipolysis in adipose tissue while inhibiting lipogenesis, mimicking the fat-metabolizing domain of hGH without engaging the full growth hormone receptor or altering IGF-1 production. Furthermore, it appears to enhance beta-3 adrenergic receptor expression and sensitivity in adipocytes, thereby increasing cyclic AMP levels, activating hormone-sensitive lipase, and facilitating fatty acid oxidation for energy utilization. Additionally, laboratory models show elevated plasma glycerol as an index of lipolysis, alongside reduced body fat accumulation without impacting insulin sensitivity or carbohydrate metabolism. These selective actions, observed in obese rodent studies and cellular assays, contribute to observed metabolic shifts, with recent research emphasizing its reassuring profile for targeted lipid pathway investigations free from typical hGH-associated drawbacks.

• Telomerase activation and hTERT expression studies in somatic cell models
• Telomere length maintenance and Hayflick limit investigations
• ALT (Alternative Lengthening of Telomeres) pathway research in cancer cell lines
• Epigenetic chromatin remodeling and DNA repair mechanism analyses
• Pineal gland function and melatonin circadian rhythm restoration studies
• Antioxidant enzyme activity and oxidative stress resilience evaluations
• Cellular senescence and replicative lifespan extension research
• Neuroendocrine aging and geroprotective bioregulator investigations

• Khavinson VK, Bondarev IE, Butyugov AA. Bull Exp Biol Med. 2003;135(6):590–592.

• Anisimov VN, Khavinson VK. Biogerontology. 2010;11(2):139–149.

• Al-Dulaimi S, Thomas R, Matta S, Roberts T. Biogerontology. 2025.

• Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Int J Mol Sci. 2025;26(6):2691.
• Anisimov VN et al. Mech Ageing Dev. 2003;124(8-9):791–796.